Send us a text

Welcome back Rounds Table Listeners! We are back today with a solo episode with Dr. Mike Fralick. This week, he discusses a recently published trial exploring the role of high-dose Vitamin D therapy in reducing disease activity in patients with clinically isolated syndrome (CIS) typical of multiple sclerosis (MS). Here we go!

1. High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Trial (0:00 – 7:35).

Announcements (7:36 – 9:15):

• Canadian physicians, 2025 CMPA Council elections are underway in Alberta and Ontario! View the candidates and cast your ballot here.
• Check out Dr. Yatin Chada's podcast, beyondMD!

And we've launched qMonthly, a monthly blog highlighting headliners and hidden gem trials published each month. Check it out here!

Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods